Literature DB >> 16704895

Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress.

R A Steingart1, I Gozes.   

Abstract

Activity-dependent neuroprotective protein (ADNP) is essential for brain formation. Here, we investigated the potential neuroprotective effects of recombinant ADNP under stress conditions. The human ADNP cDNA was sub-cloned into a vector that contains VP22, a Herpes virus protein that may allow penetration of fused proteins through cellular membranes. When incubated with pheochromocytoma (PC12) cells, a neuronal model, VP22-ADNP was associated with the cells after a 25-min incubation period. Pre-incubation with VP22-ADNP enriched protein fractions protected against beta amyloid peptide toxicity and oxidative stress (H2O2) in PC12 cells. VP22 by itself was devoid of protective activity. Furthermore, the pro-apoptotic protein p53 increased by 3.5-fold from control levels in the presence of H2O2, while treatment with VP22-ADNP prior to H2O2 exposure significantly reduced the p53 protein levels. ADNP expression was previously shown to oscillate as a function of the estrus cycle in the mouse arcuate nucleus, these oscillations are now correlated with increased cellular protection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704895     DOI: 10.1016/j.mce.2006.03.029

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

Review 1.  Neuroprotective protein and carboxypeptidase E.

Authors:  Hisatsugu Koshimizu; Vladimir Senatorov; Y Peng Loh; Illana Gozes
Journal:  J Mol Neurosci       Date:  2009-01-23       Impact factor: 3.444

2.  Activity-dependent neuroprotective protein modulates its own gene expression.

Authors:  Moutasem S Aboonq; Sylvia A Vasiliou; Kate Haddley; John P Quinn; Vivien J Bubb
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

3.  Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's disease.

Authors:  Jessica Ciesler; Youssef Sari
Journal:  Open J Neurosci       Date:  2013-04-08

4.  Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse.

Authors:  Y Sari
Journal:  Neuroscience       Date:  2008-11-21       Impact factor: 3.590

5.  ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance.

Authors:  Shmuel Mandel; Irit Spivak-Pohis; Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

6.  Novel evolutionary-conserved role for the activity-dependent neuroprotective protein (ADNP) family that is important for erythropoiesis.

Authors:  Efrat Dresner; Anna Malishkevich; Carmit Arviv; Shelly Leibman Barak; Shahar Alon; Rivka Ofir; Yoav Gothilf; Illana Gozes
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

7.  The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.

Authors:  S Oz; O Kapitansky; Y Ivashco-Pachima; A Malishkevich; E Giladi; N Skalka; R Rosin-Arbesfeld; L Mittelman; O Segev; J A Hirsch; I Gozes
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

8.  Protein profiling reveals antioxidant and signaling activities of NAP (Davunetide) in rodent hippocampus exposed to hypobaric hypoxia.

Authors:  Niroj Kumar Sethy; Narendra Kumar Sharma; Mainak Das; Kalpana Bhargava
Journal:  J Mol Neurosci       Date:  2014-07-20       Impact factor: 3.444

9.  Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry.

Authors:  Joanna M Hill; Janet M Hauser; Lia M Sheppard; Daniel Abebe; Irit Spivak-Pohis; Michal Kushnir; Iris Deitch; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

10.  NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).

Authors:  Illana Gozes; Inna Divinski; Inbar Piltzer
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.